Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAscent Resources Regulatory News (AST)

Share Price Information for Ascent Resources (AST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.10
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.20 (10.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2.10
AST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Funding Update and Resolution of Warranty Issues

18 Dec 2013 13:00

RNS Number : 8715V
Ascent Resources PLC
18 December 2013
 



Ascent Resources plc

 

("Ascent" or the "Company")

 

Funding Update, Issue of Equity and Resolution of Warranty Issues

 

Ascent Resources plc, the AIM listed European oil and gas exploration and production company is pleased to update the market as follows:

 

Funding update

 

The Company has entered into a subscription agreement with Global Power Sources s.r.l. ("GPS"), the purchaser of Ascent's former Italian Subsidiary, Ascent Resources Italia s.r.l. ("Ascent Italia") for the issue of 83,333,334 new ordinary shares of 0.1 pence each in the capital of the Company ("Subscription Shares") at an issue price of 1.2p per Ordinary Share, raising £1 million for the Company (the "Subscription"). The Subscription Shares will be subscribed in two tranches of £500,000 each in January and February 2014.

 

Additionally Ascent has entered into a short-term loan facility of up to £500,000 with Darwin Strategic Limited (the "Darwin Facility"). Under the terms of the Darwin Facility, a 5% commitment fee will be payable on the full amount on first draw down. Interest will be payable at the rate of 12% per annum on any amounts drawn down. The Darwin Facility, which is not convertible, will be repayable in full, together with accrued interest, after 6 months.

 

The funds resulting from the Subscription and the Darwin Facility will allow the Company to continue to make progress towards securing the necessary permits required for gas processing facilities and pipelines in Petišovci in advance of full project finance for the construction phase of the development.

 

Resolution of warranty issues

 

As announced on 22 July 2013, the Company sold its Italian Subsidiary, Ascent Italia, to GPS. The Company has since become aware of a number of matters, which may result in warranty claims under the terms of the Sale & Purchase Agreement ("SPA").

 

While no formal legal steps have yet been taken by GPS in relation to these matters and no admission of liability has been made by Ascent, the Company has taken legal advice on its position and the Company and GPS have agreed that, in return for a full waiver of any and all claims or potential claims by GPS under the SPA, Ascent will issue 275 million ordinary shares of 0.1 pence each in the share capital of the Company to GPS (the "Settlement Shares") ("the Settlement"). 268 million Settlement Shares will be issued immediately, credited as fully paid, at a price of 1.2p per Ordinary Share. A further 7 million Settlement Shares will be issued, credited as fully paid, following approval by shareholders of a resolution authorising the issuance of these shares which will be put to shareholders at the next General Meeting, or Annual General Meeting of the Company.

 

An Orderly Markets agreement for a period of 12 months has been entered into by the Company and GPS in connection with the Settlement Shares, under which disposals of the Settlement Shares (except in acceptance of an offer for the Company) must be effected through the Company's brokers with a view to maintaining an orderly market in the Company's shares.

 

Admission and Settlement

 

Application has been made for the admission to trading on AIM of 268 million Settlement Shares ("Admission"). Admission is expected to occur on 20 December 2013. As at Admission, Ascent will have 1,451,114,395 Ordinary Shares in issue. A further announcement regarding the admission to trading on AIM of the first tranche of Subscription Shares, which is expected to be in January 2014, will be made in due course.

 

Following Admission, the GPS or its affiliates ("GPS Group") will be beneficially interested in 300,126,793 Ordinary Shares, representing 20.7 per cent. of the issued share capital, and 11.7 per cent. on a fully diluted basis.

 

Under the terms of the Settlement and the Subscription, so long as GPS Group holds more than 20 per cent. of the issued share capital of Ascent before the conversion of existing convertible Loan Notes, GPS has the right to nominate a director to the Board of the Company. Further details will be announced as and when a director is appointed.

 

 

Len Reece, Ascent's Chief Executive Officer, commented:

 

"We are pleased to have resolved the issues surrounding Ascent Italia's assets in a constructive and amicable manner and welcome GPS as a significant and supportive shareholder. The funds provided from the Subscription and the Darwin Facility will allow permitting and other preparatory works to continue at full pace, while project finance for the construction phase is finalised."

 

 

Enquiries:

 

Ascent Resources plc.

Clive Carver / Len Reece

Tel: +44 (0)20 7251 4905

 

finnCap (Nominated Adviser and Broker)

Matthew Robinson / Charlotte Stranner

Tel: +44 (0) 20 7220 0500

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGGGRWPUPWGPR
Date   Source Headline
3rd Feb 20212:05 pmRNSSecond Price Monitoring Extn
3rd Feb 20212:00 pmRNSPrice Monitoring Extension
2nd Feb 20214:41 pmRNSSecond Price Monitoring Extn
2nd Feb 20214:35 pmRNSPrice Monitoring Extension
2nd Feb 20212:06 pmRNSSecond Price Monitoring Extn
2nd Feb 20212:00 pmRNSPrice Monitoring Extension
29th Jan 20214:39 pmRNSTotal Voting Rights
27th Jan 20216:26 pmRNSHolding(s) in Company
25th Jan 20215:44 pmRNSHolding(s) in Company
22nd Jan 20215:48 pmRNSHolding(s) in Company
13th Jan 20215:28 pmRNSHolding(s) in Company
11th Jan 20217:00 amRNSExercise of warrants and loan repayment
6th Jan 20212:17 pmRNSIssue of Consultancy Shares
31st Dec 202012:15 pmRNSTotal Voting Rights
14th Dec 202011:50 amRNSDirector/PDMR Shareholding
11th Dec 20208:00 amRNSDirector/PDMR Shareholding
10th Dec 20204:05 pmRNSHolding(s) in Company
9th Dec 20207:00 amRNSHolding(s) in Company
7th Dec 20208:52 amRNSHolding(s) in Company
4th Dec 20204:40 pmRNSSecond Price Monitoring Extn
4th Dec 20204:35 pmRNSPrice Monitoring Extension
4th Dec 20207:00 amRNSHolding(s) in Company
1st Dec 20207:00 amRNSNew Funding
27th Nov 20207:53 amRNSHolding(s) in Company
18th Nov 20205:49 pmRNSRevised block listing application
16th Nov 202012:23 pmRNSBlock listing application
11th Nov 20204:49 pmRNSHolding(s) in Company
11th Nov 20203:27 pmRNSHolding(s) in Company
11th Nov 20201:04 pmRNSHolding(s) in Company
9th Nov 20208:37 amRNSHolding(s) in Company
5th Nov 20204:44 pmRNSIssue of Consultancy Shares
2nd Nov 20207:00 amRNSHolding(s) in Company
2nd Nov 20207:00 amRNSCuba Update: MOU Extension
30th Oct 20204:40 pmRNSSecond Price Monitoring Extn
30th Oct 20204:35 pmRNSPrice Monitoring Extension
30th Oct 20202:05 pmRNSSecond Price Monitoring Extn
30th Oct 20202:00 pmRNSPrice Monitoring Extension
30th Oct 202012:34 pmRNSExercise of warrants and debt update
30th Oct 202011:58 amRNSHolding(s) in Company
30th Oct 202011:05 amRNSSecond Price Monitoring Extn
30th Oct 202011:00 amRNSPrice Monitoring Extension
30th Oct 20209:05 amRNSSecond Price Monitoring Extn
30th Oct 20209:00 amRNSPrice Monitoring Extension
29th Oct 20205:30 pmRNSExercise of warrants and debt update
27th Oct 202011:06 amRNSSecond Price Monitoring Extn
27th Oct 202011:00 amRNSPrice Monitoring Extension
27th Oct 20207:03 amRNSHolding(s) in Company
26th Oct 20205:56 pmRNSExercise of warrants and debt reduction
26th Oct 20208:00 amRNSLoan Facility Update
26th Oct 20207:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.